Global healthtech company Alcidion has made three appointments to its UK-based team, with one internal promotion and two external recruits.
TechnologyDoctorlink: Rupert Spiegelberg
An online health and symptom assessment platform for the NHS, Doctorlink, has appointed Rupert Spiegelberg as chief executive.
Spiegelberg will be responsible for taking the Doctorlink platform global, to public and private healthcare providers around the world.
Spiegelberg was most recently chief executive of IDNow, an artificial intelligence-powered digital identity company.
Prior to that, Spiegelberg was chief executive of Investis Inc, a global software as a solution communications platform, based in New York.
Rupert succeeds former Doctorlink chief executive and founder, Andrew Gardner, who will remain as a special advisor to the board.
Doctorlink currently provides 24/7 access to digital symptom assessment to more than 10 million NHS patients across 1,350 GP practices.
Patients can access the platform through the Doctorlink app, available on Apple and Google Play.
Commenting on his new role, Spiegelberg said: “Our success in the NHS has shown that Doctorlink’s platform is head and shoulders above the competition and we are excited to be rolling this technology out globally. The benefits in improving patient access to healthcare, shortening waiting times and helping NHS England to save costs makes it a very compelling proposition for primary healthcare providers and insurers.”
Latest Executive Moves
Cambridge-based techbio company Qureight has appointed Craig Rhodes as head of partnerships, to lead engagements with pharmaceutical organisations.
TechnologyCare provider Active Pathways has appointed Alistair Hannah-Briggs as business development director.
Social care